Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Brant Delafontaine

Awards & Distinctions

10 Results

2024

Preliminary safety and pharmacokinetics of the MET-TKI DO-2 in patients with advanced solid tumors harboring MET aberrations : a phase I study

T. PereraB. SikkemaB. DekeyserP. de BruijnF. ZammitR. GalotJ. P. Machielsjean-pascalBrant DelafontaineSylvie RotteyA. Swalduz et al.

2023

Immunotherapeutic targeting and PET imaging of DLL3 in small-cell neuroendocrine prostate cancer

Jonathan ChouEmily A. EgusaSinan WangMichelle L. BaduraFei LeeAnil P. BidkarJun ZhuTanushree ShenoyKai TrepkaTroy M. Robinson et al.

A1 Journal Article in CANCER RESEARCH

2022

PRECISION : the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment

J. ThouveninC. Van MarckeL. DecosterG. RaicevicK. PunieM. VandenbulckeR. SalgadoE. Van ValckenborghB. MaesS. Joris et al.

A1 Journal Article in ESMO OPEN

2021

Safety and immunogenicity of LY3415244, a bispecific antibody against TIM-3 and PD-L1, in patients with advanced solid tumors

Matthew D. HellmannNicoletta BiviBoris CalderonToshio ShimizuBrant DelafontaineZhuqing Tina LiuAnna M. SzpurkaVictoria CopelandF. Stephen HodiSylvie Rottey et al.

A1 Journal Article in CLINICAL CANCER RESEARCH

2020

An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations

Brant DelafontaineC. De BackerB. BeuselinckP. DebruyneL. D’HondtC. GennigensT. GilC. VulstekeN. Martinez-ChanzaA. Verbiest et al.

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

2019

Switchability of gabapentin formulations : a randomized trial to assess bioequivalence between Neurontin and Gabasandoz on the individual subject level

Griet Van LanckerLucas Van BortelBrant DelafontaineKoen BousseryEleonora SwartAbdel ChahbouniJan Van BocxlaerPieter Colin

A1 Journal Article in CLINICAL PHARMACOLOGY & THERAPEUTICS

2017

Checkpoint inhibition : new treatment options in urologic cancer

Daan De MaeseneerBrant DelafontaineSylvie Rottey

A1 Journal Article in ACTA CLINICA BELGICA

KH176 under development for rare mitochondrial disease : a first in man randomized controlled clinical trial in healthy male volunteers

Saskia KoeneEdwin SpaansLucas Van BortelGriet Van LanckerBrant DelafontaineFabio BadiliniJulien BeyrathJan Smeitink

A1 Journal Article in ORPHANET JOURNAL OF RARE DISEASES

2016

Virussen in de behandeling van kanker : oncolytische virotherapie

Brant DelafontaineGriet Van LanckerLucas Van BortelSylvie Rottey

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

2015

Evaluation of a Cerebral-Blood-Volume (CBV) pharmaco-MRI (phMRI) assay utilizing low (0.1mg/70kg) and high (0.2mg/70kg) dose buprenorphine infusion and a novel USPIO contrast agent (Ferumoxytol) in healthy human subjects

Richard BaumgartnerArie StruykJeff EvelhochCynthia GarganoFrancheska Colon GonzalezHaiying LiuRuben DeclercqHans VerheydenIngeborg HeirmanHANS DE PLA et al.